MediPharm Labs Completes First CBD Metered-Dose Inhaler Shipment to Panama

09:04 AM EDT, 10/13/2026 (MT Newswires) -- MediPharm Labs (LABS.TO) completed its first commercial shipment of cannabidiol (CBD) metered-dose inhalers to Adeiwa Pharma, representing the company's first sale into Panama, it said Tuesday. The company expects the products to reach patients in October. "We look forward to working with Adeiwa Pharma to bring our CBD metered-dose inhaler to patients in Panama and to continue expanding access to high-quality cannabinoid medicines in regulated international markets," said MediPharm Labs' Interim Chief Executive Officer and Chief Financial Officer Greg Hunter. MediPharm shares last traded Oct.9, closing at CA$0.07 on the Toronto Stock Exchange.